<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00508196</url>
  </required_header>
  <id_info>
    <org_study_id>190906ver3</org_study_id>
    <nct_id>NCT00508196</nct_id>
  </id_info>
  <brief_title>Endothelial Function and Cardiac Output in RV Pacing</brief_title>
  <official_title>Endothelial Function and Cardiac Output in Right Ventricular Pacing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Dundee</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Dundee</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pacing from the right ventricle (as is current practice in patients implanted with permanent
      pacemakers for bradycardia), has been associated with worse outcomes particularly in heart
      failure patients. Recent clinical trials suggest that chronic right ventricular pacing (VP)
      is associated with worsening heart failure, increased strokes and atrial fibrillation.
      Hemodynamically, right VP results in delayed activation and contraction of the LV which can
      give rise to functional mitral regurgitation, shortened diastolic filling time and thus
      reduced coronary filling, as well as abnormal arterial pulsatile flow. The mechanisms for the
      deleterious effects of right VP in heart failure patients have not been previously
      investigated. Our aim of this study is therefore to investigate the hemodynamic effects of
      right VP in stable heart failure patients in terms of exercise cardiac output (CO, an
      important measure of myocardial function and prognosis), as well as endothelial function
      which may be deranged as a result of abnormal arterial pulsatile flow.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Aims The aim of this study is to investigate the effect of right ventricular pacing on
      CO at rest and exercise, and on endothelial function and B-type natriuretic peptide, BNP, in
      patients with heart failure.

      Methods: Thirty patients with dual chamber pacemakers for sinus node disease will be
      recruited: 15 controls with normal LV function and 15 with stable impaired LV function
      (ejection fraction &lt;40%). The pacemaker will be programmed to pace to back-up pacing at 55bpm
      in the atrial only (AAI, no right VP) for one week (baseline); and than programmed to
      overdrive pacing at 70-80bpm, randomised to either to dual chamber, DDD (sequential atrial
      and ventricular pacing) with a short AV delay (to ensure maximal right VP) or AAI (no RV
      pacing), for 1 week. There will be a crossover after a 1 week washout at backup AAI pacing at
      55 bpm. Resting and exercise CO will be measured at the end of each pacing mode intervention
      using the Inocor system (a validated non invasive method of CO measurement, using inhaled
      inert gas equilibriums). Endothelial function will be measured non-invasively at the same
      time points, as will plasma BNP, a measure of LV strain. Patients with unstable heart failure
      or angina will be excluded.

      Study Endpoints: Rest and exercise CO; and endothelial function and BNP with and without RV
      pacing, in patients with preserved and impaired LV function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2006</start_date>
  <completion_date type="Actual">July 2007</completion_date>
  <primary_completion_date type="Actual">July 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial Function Assessed by Flow Mediated Vasodilatation</measure>
    <time_frame>1 week</time_frame>
    <description>Flow mediated vasodilatation as measured by reactive hyperaemia peripheral arterial tonometry signal using EndoPAT software, Itamar.
A post-occlusion to pre-occlusion ratio is calculated by the EndoPAT software, providing the EndoPAT index (EnFI)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>B-type Natriuretic Pepetide</measure>
    <time_frame>1 week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output</measure>
    <time_frame>1 week</time_frame>
    <description>measured at peak exercise on a standard exercise bicycle, measured non-invasively using the inert gas rebreathing technique (Innocor, Innovision A/S, Odense, Denmark).</description>
  </secondary_outcome>
  <enrollment type="Actual">22</enrollment>
  <condition>Bradycardia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RVP-min</intervention_name>
    <description>DDD pacing with long AV delay</description>
    <other_name>DDD Long</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>RVP-max</intervention_name>
    <description>DDD pacing with short AV delay</description>
    <other_name>DDD short</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Dual chamber pacemaker

          -  Intact AV node function

        Exclusion Criteria:

          -  Unstable angina, heart failure

          -  Inability to exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allan Struthers, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Dundee</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ninewells Hospital and medical School</name>
      <address>
        <city>Dundee</city>
        <zip>DD1 9SY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>July 25, 2007</study_first_submitted>
  <study_first_submitted_qc>July 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2007</study_first_posted>
  <results_first_submitted>October 24, 2016</results_first_submitted>
  <results_first_submitted_qc>March 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">March 18, 2019</results_first_posted>
  <last_update_submitted>March 15, 2019</last_update_submitted>
  <last_update_submitted_qc>March 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>right ventricular pacing</keyword>
  <keyword>endothelial function</keyword>
  <keyword>cardiac output</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects previously implanted with a dual-chamber pacemaker for SND were recruited from the Ninewells Hospital and Medical School pacemaker clinic. No subject was pacemaker dependent and the indication for pacing was intermittent sinus arrest or sinus bradycardia.</recruitment_details>
      <pre_assignment_details>Prior to randomization, as pre-study right ventricular pacing was variable among the subjects, pacing was programmed to produce minimal right ventricular pacing (using single-chamber atrial pacing or dual-chamber mode with long AV delay) for a minimal washout period of â‰¥1 week.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>RVP-Max First, Then RVP-Min</title>
          <description>maximum RV pacing programmed (short AV delay) for 1 week, then at least 1 week washout, then minimum RV pacing (long AV delay)</description>
        </group>
        <group group_id="P2">
          <title>RVP-Min First, Then RVP-Max</title>
          <description>Minimum RV pacing programmed (long AV delay) for 1 week, then at least 1 week washout, then maximum RV pacing (short AV delay)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>All Participants</title>
          <description>All subjects had the right ventricular lead implanted at the right ventricular apex. No subject was pacemaker dependent and the indication for pacing was intermittent sinus arrest or sinus bradycardia. Subjects with ongoing angina or heart failure symptoms, known AV node disease, bundle branch block, age &gt;80 years, atrial fibrillation, or inability to exercise, were excluded.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="22"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.7" spread="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Endothelial Function Assessed by Flow Mediated Vasodilatation</title>
        <description>Flow mediated vasodilatation as measured by reactive hyperaemia peripheral arterial tonometry signal using EndoPAT software, Itamar.
A post-occlusion to pre-occlusion ratio is calculated by the EndoPAT software, providing the EndoPAT index (EnFI)</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RVP-min</title>
            <description>Minimal RV pacing , with long AV delay programmed in DDD mode</description>
          </group>
          <group group_id="O2">
            <title>RVP-Max</title>
            <description>Maximum RV pacing with short AV delay programmed in DDD mode</description>
          </group>
        </group_list>
        <measure>
          <title>Endothelial Function Assessed by Flow Mediated Vasodilatation</title>
          <description>Flow mediated vasodilatation as measured by reactive hyperaemia peripheral arterial tonometry signal using EndoPAT software, Itamar.
A post-occlusion to pre-occlusion ratio is calculated by the EndoPAT software, providing the EndoPAT index (EnFI)</description>
          <units>EndoPAT index (EnFI)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.96" spread=".37"/>
                    <measurement group_id="O2" value="1.73" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>B-type Natriuretic Pepetide</title>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RVP-min</title>
            <description>Minimal RV pacing , with long AV delay programmed in DDD mode</description>
          </group>
          <group group_id="O2">
            <title>RVP-Max</title>
            <description>Maximum RV pacing with short AV delay programmed in DDD mode</description>
          </group>
        </group_list>
        <measure>
          <title>B-type Natriuretic Pepetide</title>
          <units>microgrammes /L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="104.3" spread="108"/>
                    <measurement group_id="O2" value="112.8" spread="80.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cardiac Output</title>
        <description>measured at peak exercise on a standard exercise bicycle, measured non-invasively using the inert gas rebreathing technique (Innocor, Innovision A/S, Odense, Denmark).</description>
        <time_frame>1 week</time_frame>
        <group_list>
          <group group_id="O1">
            <title>RVP-min</title>
            <description>Minimal RV pacing , with long AV delay programmed in DDD mode</description>
          </group>
          <group group_id="O2">
            <title>RVP-Max</title>
            <description>Maximum RV pacing with short AV delay programmed in DDD mode</description>
          </group>
        </group_list>
        <measure>
          <title>Cardiac Output</title>
          <description>measured at peak exercise on a standard exercise bicycle, measured non-invasively using the inert gas rebreathing technique (Innocor, Innovision A/S, Odense, Denmark).</description>
          <units>L/min</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="22"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.65" spread="3.15"/>
                    <measurement group_id="O2" value="7.05" spread="2.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>RVP-min</title>
          <description>Minimal RV pacing , with long AV delay programmed in DDD mode</description>
        </group>
        <group group_id="E2">
          <title>RVP-Max</title>
          <description>Maximum RV pacing with short AV delay programmed in DDD mode</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="22"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>DR Anna Maria Choy</name_or_title>
      <organization>University of Dundee</organization>
      <phone>01382 383482</phone>
      <email>a.choy@dundee.ac.uk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

